XLO — Xilio Therapeutics Share News
0.000.00%
Last trade - 00:00- $49.81m
- -$86.23m
- $43.77m
U.S. STOCKS ON THE MOVE-Chefs' Warehouse, Aptose Biosciences, Electromed
U.S. STOCKS ON THE MOVE-PPG Industries, CME Group, WiSA Technologies
Xilio soars after tie-up with AbbVie to develop cancer treatments
U.S. STOCKS ON THE MOVE-Xilio Therapeutics, Intel, Lithia Motors
Xilio jumps after collaboration with AbbVie to develop cancer treatments
Brief: Abbvie And Xilio Therapeutics Announce Collaboration
Brief: Abbvie And Xilio Therapeutics Announce Collaboration
Brief: Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Xilio Therapeutics Announces Initial Clinical Trial Data From Phase 1C Dose Escalation For Vilastobart
Xilio Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Xilio Therapeutics On Sept 10, Got Deficiency Letter From Nasdaq That Co Was Not In Compliance With Minimum Bid Requirement
Brief: Xilio Therapeutics Q2 Net Income USD -13.925 Million
Brief: Xilio Therapeutics Increased Size Of Board To Nine Directors
Brief: Xilio Therapeutics Appoints Aoife Brennan And James Shannon To Its Board Of Directors
Brief: Xilio Therapeutics Q1 Net Income USD -17.203 Million
Brief: Gilead Sciences Reports 19.9% Passive Stake In Xilio Therapeutics As Of March 27 - SEC Filing
U.S. RESEARCH ROUNDUP-Braze, Gulfport Energy, Maplebear